HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,305-2,316 of 4,505
Drug study icon
CompletedNCT00140192

Creatine Treatment in Psychiatric Disorders

Official study title

Creatine as a New Treatment for Schizophrenia:A Double-Blind Trial

This study has finished and is no longer accepting participants.

In Beersheva
SchizophreniaMedication studyAges 18–60
Countries
Israel
Sponsor
Beersheva Mental Health Center
Other study type icon
CompletedNCT03317769

Creating Live Interactions to Mitigate Barriers

Official study title

Creating Live Interactions to Mitigate Barriers (CLIMB): A Mobile Intervention to Improve Social Functioning in People With Schizophrenia

This study has finished and is no longer accepting participants.

In San Francisco
SchizophreniaInterventional studyAges 18–60
Countries
United States
Sponsor
Posit Science Corporation
Drug study icon
CompletedNCT02298985

Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients

Official study title

Curcumin as add-on to Antipsychotic Treatment in Chronic Schizophrenia Patients: A Randomized, Double-Blind, Placebo-controlled Study

This study has finished and is no longer accepting participants.

Multiple locations, including Beersheva
SchizophreniaMedication studyAges 18–60
Countries
Israel
Sponsor
Beersheva Mental Health Center
Drug study icon
CompletedNCT03669250

CVN058 Effect on Mismatch Negativity in Schizophrenics

Official study title

A Placebo-Controlled Study to Evaluate the Effect of a Single Dose of CVN058 on Mismatch Negativity in Subjects With Stable Schizophrenia

This study has finished and is no longer accepting participants.

In New York
SchizophreniaMedication studyAges 18–50
Countries
United States
Sponsor
Cerevance Alpha, Inc.
Behavioral study icon
CompletedNCT00963924

D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia

Official study title

A Placebo-controlled Trial of D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia

This study has finished and is no longer accepting participants.

In Boston
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT02156908

D-serine and Cognitive Remediation in Schizophrenia

Official study title

D-serine and Cognitive Remediation in Schizophrenia: Open Label Pilot

This study has finished and is no longer accepting participants.

In Orangeburg
SchizophreniaMedication studyAges 18–64
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Drug study icon
SuspendedNCT05046353

D-serine AudRem: R33 Phase

Official study title

D-serine Augmentation of Neuroplasticity-based Auditory Learning in Schizophrenia: R33 Phase

Recruitment is currently suspended.

In New York
SchizophreniaMedication studyAges 18–50
Countries
United States
Sponsor
New York State Psychiatric Institute
Drug study icon
CompletedNCT03711500

D-serine Augmentation of Neuroplasticity

Official study title

D-serine Augmentation of Neuroplasticity Based Auditory Learning in Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including New York
SchizophreniaMedication studyAges 18–50
Countries
United States
Sponsor
New York State Psychiatric Institute
Drug study icon
CompletedNCT00826202

D-serine for the Schizophrenia Prodrome

Official study title

D-Serine vs Placebo for the Schizophrenia Prodrome

This study has finished and is no longer accepting participants.

Multiple locations, including New Haven
SchizophreniaMedication studyAges 13–35
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.